Every spring and summer, hundreds of millions of people worldwide experience the same miserable ritual: runny nose, itchy eyes, sneezing fits, and a general sense that the outdoors has declared war on their immune system. Allergic rhinitis — commonly known as hay fever — affects an estimated 10-30% of the global population, and the numbers are rising.

For most sufferers, the approach is reactive: wait for symptoms to appear, then reach for antihistamines and nasal sprays. This works to varying degrees, but it treats symptoms while leaving the underlying immunological problem untouched. The allergy returns every season, often getting worse over time.

There is, however, a treatment that addresses the root cause — one that can reduce symptoms for years after completion and may even prevent the progression to asthma. It is called allergen-specific immunotherapy (AIT), and according to the European Academy of Allergy and Clinical Immunology (EAACI) guidelines, it should be started at least two to four months before pollen season begins. That makes autumn and winter the ideal window to begin.

This guide covers everything you need to know: how AIT works, who qualifies, what the treatment involves, what medications are available for symptom relief, and how to track your allergy symptoms effectively to make better treatment decisions.

What Happens in Your Body During an Allergic Reaction

To understand why immunotherapy works, you first need to understand what goes wrong during an allergic reaction.

When a person with pollen allergy inhales pollen particles, their immune system misidentifies these harmless proteins as dangerous invaders. On first exposure, specialized immune cells (B cells) produce immunoglobulin E (IgE) antibodies specific to that pollen protein. These IgE antibodies attach to mast cells — immune cells that are densely packed in the mucous membranes of your nose, eyes, and airways.

On subsequent exposures, pollen proteins bind to the IgE already sitting on mast cells, triggering those cells to release a flood of inflammatory mediators: histamine, leukotrienes, prostaglandins, and cytokines. Histamine alone causes blood vessel dilation (nasal congestion), increased mucus production (runny nose), nerve stimulation (itching and sneezing), and smooth muscle contraction (in the airways, contributing to asthma).

This is a Type I hypersensitivity reaction — an inappropriate immune response to an environmental protein that poses no actual threat. A comprehensive review in Nature Reviews Immunology describes how this cascade involves both an immediate phase (within minutes) and a late phase (4-8 hours later) that brings in additional inflammatory cells and can cause prolonged symptoms.

The critical point: allergic rhinitis is not just a nuisance. Left untreated, it can progress. Studies show that people with untreated allergic rhinitis have a significantly higher risk of developing asthma, and that the range of allergens a person reacts to tends to expand over time — a phenomenon called polysensitization.

The Two Main Treatment Approaches: Symptomatic Relief vs. Disease Modification

Treatment for allergic rhinitis falls into two fundamentally different categories.

Symptomatic Relief (Pharmacotherapy)

These medications manage symptoms but do not alter the underlying immune response:

  • Second-generation antihistamines (cetirizine, loratadine, fexofenadine, bilastine): Block histamine H1 receptors. Effective for sneezing, itching, and runny nose, less effective for congestion. Modern antihistamines cause minimal drowsiness compared to older drugs like diphenhydramine.
  • Intranasal corticosteroids (fluticasone, mometasone, budesonide): The single most effective class of medication for allergic rhinitis according to NICE clinical guidelines. They reduce inflammation directly in the nasal passages and address all symptoms including congestion.
  • Leukotriene receptor antagonists (montelukast): Block another inflammatory pathway. Useful as add-on therapy, particularly when asthma is also present.
  • Decongestants (oxymetazoline nasal spray, pseudoephedrine): Provide rapid congestion relief but must not be used for more than 3-5 consecutive days due to rebound congestion (rhinitis medicamentosa).
  • Cromones (cromoglicic acid): Mast cell stabilizers that work preventively. Must be started before allergen exposure and used consistently.

These medications are essential tools — many allergy sufferers rely on them successfully for years. But they work only while you take them. Stop the medication, and symptoms return.

Disease Modification (Allergen Immunotherapy)

AIT is the only treatment that can change the course of allergic disease. A landmark review published in the Journal of Allergy and Clinical Immunology describes it as the only intervention capable of inducing long-term tolerance to allergens. Unlike symptomatic medications, the benefits of AIT can persist for years after treatment completion.

How Allergen Immunotherapy Actually Works

The principle behind AIT is elegant: by gradually exposing the immune system to increasing doses of the offending allergen, you can retrain it to stop overreacting.

As described in the Nature Reviews Immunology analysis of AIT mechanisms, the treatment works through several overlapping pathways:

  1. Immune deviation: AIT shifts the immune response from a Th2-dominated profile (which drives allergic inflammation) toward a Th1/regulatory T cell profile. Regulatory T cells actively suppress the allergic response.

  2. Blocking antibody production: The immune system begins producing IgG4 antibodies that compete with IgE for allergen binding. These "blocking antibodies" intercept allergen molecules before they can trigger mast cells.

  3. Mast cell and basophil desensitization: Over time, mast cells become less reactive to allergen exposure, releasing fewer inflammatory mediators.

  4. Reduced tissue inflammation: The late-phase allergic response diminishes, with fewer eosinophils and other inflammatory cells recruited to the nasal mucosa.

These changes build gradually over months and years of treatment, which is why AIT requires commitment — typically three to five years of consistent therapy.

There are two delivery methods:

  • Subcutaneous immunotherapy (SCIT) — allergy shots: Allergen extracts are injected under the skin, starting with very low doses during a "build-up phase" (weekly injections for 3-6 months) and then maintaining at the maximum tolerated dose (monthly injections for 3-5 years). Each injection must be administered in a medical setting with a 30-minute observation period. UpToDate's clinical review reports that SCIT reduces symptom scores by 30-40% and medication use by a similar margin.

  • Sublingual immunotherapy (SLIT) — tablets or drops placed under the tongue: The first dose is given under medical supervision, but subsequent doses are taken at home daily. SLIT is generally considered safer than SCIT, with most side effects limited to local reactions (oral itching, swelling). Clinical evidence reviewed in UpToDate shows that SLIT tablets are effective for grass pollen, tree pollen (birch), house dust mite, and ragweed allergies.

Who Should Consider Immunotherapy — and Who Should Not

AIT is not for everyone, and proper patient selection is critical for both safety and efficacy.

Good Candidates for AIT

According to the EAACI guidelines, AIT should be considered when:

  • Symptoms are moderate to severe despite optimal pharmacotherapy
  • The patient wants to reduce long-term medication dependence
  • The specific allergen trigger has been clearly identified through IgE blood testing or skin prick testing
  • The patient can commit to 3-5 years of treatment

Diagnosis First: Identifying Your Triggers

Before starting AIT, you need a precise diagnosis. This involves two possible tests:

Skin prick testing (SPT): Small amounts of allergen extracts are placed on the skin (usually the forearm), and the skin is lightly pricked. A positive result — a raised, itchy bump (wheal) — appears within 15-20 minutes. SPT is rapid, inexpensive, and has high sensitivity.

Specific IgE blood testing: A blood sample is analyzed for IgE antibodies against specific allergens. This is useful when skin testing is not possible (e.g., if the patient is taking antihistamines that would suppress the skin reaction, or has severe skin conditions).

Important: testing should be guided by clinical history. Testing for "everything" without suspicion leads to false positives and misdiagnosis. Your allergist should test for allergens that match your symptom timing and exposure patterns.

Contraindications

The EAACI position paper notes that absolute contraindications are actually few:

  • Severe or uncontrolled asthma (FEV1 below 70% predicted)
  • Active systemic autoimmune disease
  • Active malignancy
  • Severe immunodeficiency

Relative contraindications include pregnancy (do not start during pregnancy, but can continue if already established), cardiovascular disease requiring beta-blockers or ACE inhibitors (which may complicate treatment of anaphylaxis), and children under five (because they cannot reliably communicate about adverse reactions).

If a person has multiple allergies for which AIT is available, it is possible to treat more than one simultaneously, though this requires careful medical oversight.

AIT Can Prevent Asthma — Especially in Children

One of the most compelling arguments for AIT is its ability to prevent disease progression. This goes beyond just reducing sneezing and itchy eyes.

A systematic review published in Allergy found that AIT significantly reduces the risk of developing asthma in children with allergic rhinitis. This is particularly important because the "allergic march" — the progression from eczema to allergic rhinitis to asthma — is a well-documented pattern in pediatric allergy.

Another study in Pediatric Allergy and Immunology demonstrated that AIT not only prevents new asthma development but also reduces the risk of new sensitizations — meaning it may stop your child from developing allergies to additional substances.

This preventive effect is a key reason why allergists increasingly recommend AIT early in the disease course, rather than waiting until symptoms become severe. The earlier the intervention, the greater the potential to alter the immune system's trajectory.

Available Allergens for Immunotherapy

AIT is available for a specific — but growing — range of allergens. The availability depends on your country and what products are approved by local regulatory agencies.

Pollen Allergens

Grass pollen: The most common trigger globally. Multiple SLIT tablets and SCIT extracts are available for grass pollen allergy. Common grasses that cause allergies include timothy grass (Phleum pratense), orchard grass (Dactylis glomerata), perennial ryegrass (Lolium perenne), Kentucky bluegrass (Poa pratensis), and sweet vernal grass (Anthoxanthum odoratum).

Tree pollen: Birch pollen AIT is available and, importantly, may provide cross-reactive benefit for allergies to related trees — including alder, hazel, hornbeam, oak, chestnut, and beech — because the major allergen proteins in these trees are structurally similar.

Weed pollen: Ragweed SLIT is available in some markets (though availability varies by country).

Non-Pollen Allergens

House dust mites: SLIT tablets are available year-round for dust mite allergy, which causes perennial (year-round) rather than seasonal symptoms.

Insect venom: Venom immunotherapy (typically SCIT) is available for bee and wasp stings and is one of the most effective forms of AIT, reducing the risk of life-threatening anaphylaxis.

Animal dander, mold: AIT products for cat, dog, and mold allergies are available in some countries but may not be registered everywhere. Check with your allergist about local availability.

Timing: Why You Need to Start Months Before Allergy Season

This is the single most important practical point about AIT for seasonal allergies: you cannot start during pollen season.

The EAACI guidelines recommend beginning SLIT 2-4 months before the expected start of the relevant pollen season. For SCIT, the build-up phase alone takes 3-6 months. This means:

  • If your symptoms start in April (tree pollen), you need to begin treatment by December-January at the latest
  • If grass pollen in June is your trigger, starting by February gives adequate lead time
  • If you react to ragweed in August, spring is your window

For perennial allergens (dust mites, animal dander), there is no seasonal constraint — treatment can begin at any time.

What Does the Treatment Schedule Look Like?

For SLIT (sublingual tablets/drops):

  • First dose: administered under medical supervision (30-60 minute observation period)
  • Subsequent doses: taken at home daily, typically placed under the tongue and held for 1-2 minutes before swallowing
  • Pre-seasonal protocols: taken for several months before and during the pollen season, repeated for 3 consecutive years
  • Continuous protocols: taken daily year-round for 3 years

For SCIT (allergy shots):

  • Build-up phase: weekly injections for 3-6 months, with gradually increasing doses
  • Maintenance phase: monthly injections at the target dose for 3-5 years
  • Each injection requires a 30-minute in-office observation period
  • The goal is to reach the maximum tolerated dose for optimal effectiveness

Gaps in treatment reduce effectiveness. Consistency matters — so before committing, make sure the schedule is practical for your life.

Side Effects and Safety

AIT is generally safe when administered properly, but it is not risk-free.

SLIT Side Effects

The most common side effects are local: oral itching, tingling, or mild swelling of the mouth and lips. These typically occur during the first few weeks and often diminish with continued treatment. Gastrointestinal symptoms (nausea, abdominal discomfort) can occur but are usually mild.

Systemic reactions (affecting the whole body) are rare with SLIT. Severe anaphylaxis has been reported but is extremely uncommon, which is why only the first dose requires medical supervision.

SCIT Side Effects

Local reactions (redness, swelling at the injection site) are common and expected. Large local reactions (swelling greater than the size of a palm) occur in a minority of patients.

Systemic reactions — including urticaria (hives), asthma exacerbation, and anaphylaxis — are more common with SCIT than SLIT, which is why every injection must be given in a medical setting. UpToDate's review of anaphylaxis risk during SCIT notes that fatal reactions are extremely rare (estimated at 1 per 2.5 million injections) but underscore the importance of the mandatory observation period.

The maximum dose provides the best clinical outcomes, but not every patient can tolerate it. Your allergist will work with you to find the highest dose you can tolerate without unacceptable side effects.

Does the Effect Last? What Happens After Treatment Ends?

This is the question everyone asks — and the honest answer is nuanced.

The effect of AIT can persist for several years after treatment completion, but it is not always permanent. Some patients maintain significant improvement for 7-12 years or longer. Others experience gradual return of symptoms, though typically milder than before treatment.

Factors that influence durability include:

  • Treatment duration: Completing the full 3-5 year course is associated with longer-lasting benefits. Stopping early reduces durability.
  • Dose achieved: Patients who tolerate and maintain higher doses tend to have better long-term outcomes.
  • Number of allergens: Monosensitized patients (allergic to one thing) may respond better than polysensitized patients.

Even when symptoms do return, many patients report that they are significantly milder than before AIT, and that they need less medication to achieve adequate control. Some patients choose to repeat a course of AIT if symptoms return after several years.

The key takeaway: AIT is the closest thing to a "cure" for allergies that currently exists, but it is more accurately described as long-term remission rather than permanent cure.

Pharmacotherapy Deep Dive: Making the Most of Symptom Relief Medications

Whether you are undergoing AIT or managing allergies with medications alone, understanding how to use these drugs effectively matters. Many people use them suboptimally.

Antihistamines: Timing Is Everything

Second-generation antihistamines (cetirizine, loratadine, fexofenadine, bilastine, desloratadine) are most effective when taken before symptoms start, not after. If you know pollen season begins in April, starting daily antihistamines in late March primes the H1 receptor blockade before the histamine flood begins.

  • Cetirizine (10 mg): Fast onset (~1 hour), slight sedation potential in some individuals
  • Loratadine (10 mg): Truly non-sedating for most people, but slightly slower onset
  • Fexofenadine (120-180 mg): Non-sedating, but absorption reduced by fruit juice
  • Bilastine (20 mg): Newer generation, non-sedating, take on empty stomach

First-generation antihistamines (diphenhydramine, chlorpheniramine) should generally be avoided for regular use due to significant sedation, cognitive impairment, and anticholinergic effects.

Intranasal Corticosteroids: The Unsung Heroes

Clinical practice guidelines consistently rank intranasal corticosteroids as the most effective single medication class for allergic rhinitis. They address nasal congestion — the symptom that antihistamines handle least well.

Key points for effective use:

  • Start early: Begin 1-2 weeks before expected allergen exposure for maximum effect
  • Use daily: Consistent daily use is far more effective than as-needed use
  • Proper technique: Aim the spray laterally (toward the ear on the same side), not straight up or toward the septum
  • Give it time: Full effect takes 1-2 weeks of daily use

Combination Therapy

For moderate-severe symptoms, combining an intranasal corticosteroid with an oral antihistamine is more effective than either alone. Some patients add a leukotriene receptor antagonist (montelukast) for additional benefit, particularly if asthma is also present.

Non-Pharmacological Strategies That Actually Help

Medications are the backbone of allergy management, but several evidence-based non-drug strategies can meaningfully reduce symptom burden.

Allergen Avoidance

  • Monitor pollen counts: Use local pollen forecast services and plan outdoor activities for low-count days. Pollen counts are typically highest in early morning and on warm, dry, windy days.
  • Keep windows closed during peak pollen season and use air conditioning with HEPA filters
  • Shower and change clothes after spending time outdoors to remove pollen from your hair and skin
  • Wear sunglasses outdoors to reduce eye exposure
  • Nasal saline irrigation: Daily rinsing with isotonic saline (using a neti pot, squeeze bottle, or saline spray) physically removes allergens from the nasal passages and reduces mucosal inflammation. Multiple studies support its efficacy as an adjunct to pharmacotherapy.

What Does Not Help

  • "Local honey" for allergies: The theory that eating local honey exposes you to local pollen and builds tolerance is not supported by evidence. Honey contains flower pollen (carried by insects), not the windborne tree and grass pollen that causes hay fever.
  • Unproven supplements and "detoxes": Many supplements marketed for allergies lack clinical evidence. Be particularly cautious about unregulated products that claim to perform immunotherapy — without standardized allergen dosing, they cannot replicate the precise immune modulation that makes AIT work.
  • Avoiding outdoors entirely: While allergen avoidance reduces exposure, complete avoidance is neither practical nor necessary for most people when proper medication is in place.

Tracking Your Allergy Symptoms: Why It Matters More Than You Think

One of the most valuable things you can do for your allergy management — whether you are on AIT, pharmacotherapy, or considering treatment options — is to systematically track your symptoms.

Here is why this matters:

For diagnosis: When you visit an allergist, a detailed record of when symptoms occur, how severe they are, and what you were doing is far more valuable than vague recollections. "I think I sneeze more in spring" is less useful than "My symptom scores peaked at 8/10 during weeks 15-20, correlating with birch and grass pollen seasons."

For treatment evaluation: How do you know if a medication is working? If you started a new antihistamine in March, having baseline symptom data from February gives you an objective comparison. This is especially important for AIT, where improvement is gradual and can be hard to perceive subjectively over months.

For pattern recognition: Tracking can reveal patterns you might otherwise miss — like the fact that your symptoms are worse on certain days of the week (outdoor exercise days?), in certain locations, or at certain times of day.

With WatchMyHealth's wellbeing tracker, you can log daily symptom severity — congestion, sneezing, eye irritation, energy levels, and overall comfort. Tracking these metrics daily during allergy season creates a detailed record that helps both you and your doctor make informed decisions about treatment adjustments.

The medication tracker is equally important here. Log your antihistamines, nasal sprays, and any AIT doses. When you can overlay your medication schedule with your symptom scores, you get a clear picture of what is working and what is not. If you notice that symptoms spike on days when you forget your intranasal corticosteroid, that visual evidence is a powerful motivator for consistency.

Cost, Insurance, and Access

AIT is a significant financial and time commitment. Understanding the cost structure helps you plan.

Cost Factors

  • Allergist consultations: Initial evaluation (including testing) plus regular follow-up visits throughout treatment
  • Allergen extracts/tablets: The cost of the AIT products themselves, which must be purchased for 3-5 years
  • Injection visits: For SCIT, each injection visit involves clinic time and a 30-minute observation period

Insurance and National Health Systems

Coverage varies enormously by country and insurance plan. In some countries, AIT is fully covered by national health systems when standard pharmacotherapy has proven insufficient. In the UK, for example, the NHS covers AIT under specific clinical criteria — typically when pharmacotherapy alone does not provide adequate control.

In other countries, patients may pay partially or fully out of pocket. Check with your insurer or national health system about coverage before beginning treatment.

Tax Benefits

In many countries, medical expenses including AIT are eligible for tax deductions or credits. Keep all receipts, prescriptions, and medical reports throughout your treatment course.

Children and Allergies: Special Considerations

Allergic rhinitis often begins in childhood, and early intervention can alter the disease trajectory.

When to Start AIT in Children

AIT can generally be started from age five onward. The lower age limit exists because the child must be able to reliably communicate about symptoms and any adverse reactions during treatment. For SLIT tablets, children must be able to hold the tablet under the tongue without swallowing it immediately.

Why Early Treatment Matters

The preventive benefits of AIT are particularly compelling in children:

  • Reduced risk of developing asthma — this alone justifies considering AIT for children with moderate-severe allergic rhinitis
  • Prevention of new sensitizations — AIT may stop the immune system from developing allergies to additional allergens
  • Improved quality of life during critical developmental years — allergic rhinitis affects school performance, sleep quality, and social participation

Vaccinations and AIT

AIT is not a contraindication to routine vaccinations. According to AAAAI practice parameters and international recommendations, vaccinations can be administered during AIT courses, though some protocols recommend spacing them from AIT doses by a few days as a precaution.

Building an Effective Allergy Management Plan

Managing seasonal allergies well is not about any single intervention — it is about building a comprehensive plan that combines the right strategies for your specific situation.

Step 1: Get a Proper Diagnosis

See an allergist for specific IgE testing or skin prick testing. Know exactly what you are allergic to and when those allergens peak in your area.

Step 2: Optimize Pharmacotherapy

Before considering AIT, make sure you are using medications correctly:

  • Start intranasal corticosteroids 1-2 weeks before season
  • Take daily antihistamines consistently (not just when symptoms are bad)
  • Use combination therapy if single agents are insufficient
  • Add nasal saline irrigation as a daily habit during season

Step 3: Consider AIT if Pharmacotherapy is Insufficient

If optimized medications do not provide adequate control, or if you want to address the root cause rather than just manage symptoms, discuss AIT with your allergist. Remember: the best time to start is 2-4 months before your allergy season.

Step 4: Track Everything

Use WatchMyHealth's medication tracker to log every dose of antihistamine, nasal spray, or AIT treatment. Use the wellbeing tracker to rate daily symptom severity. Over weeks and months, this data becomes invaluable for:

  • Seeing objective improvement (or identifying when a medication change is needed)
  • Providing your allergist with detailed, quantified information at appointments
  • Understanding your personal patterns — which days are worst, which interventions help most
  • Staying motivated during multi-year AIT by seeing the gradual trend of improvement

Step 5: Plan for Next Season Now

Once this year's allergy season ends, review your data. Was your management adequate? Do you need to add or change medications? Is it time to discuss AIT? The months after allergy season — autumn and winter — are exactly when these decisions should be made and new treatments started.

The Bigger Picture: Allergies in a Changing Climate

Seasonal allergy management is becoming more important, not less. Multiple studies have documented that climate change is extending pollen seasons — earlier spring onset, later autumn frost — and increasing total pollen production. Urbanization and air pollution may also increase allergen potency and prime the immune system for allergic sensitization.

This means that even people who have never had allergies may develop them, and those who already have allergies may find their symptoms worsening over time. Having a proactive management strategy — understanding your triggers, using medications effectively, considering AIT when appropriate, and tracking your symptoms systematically — is not just about comfort. It is about maintaining your quality of life, protecting your lung health, and making informed decisions with your healthcare team.

Allergic rhinitis is one of the most treatable chronic conditions in medicine. The tools exist — from antihistamines to immunotherapy to digital symptom tracking. The gap is usually not in available treatments, but in the timing, consistency, and quality of how those treatments are applied. Start early. Track diligently. Adjust based on data, not guesswork.